{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:39:36Z","timestamp":1792460376717,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA159712"],"award-info":[{"award-number":["R01 CA159712"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 CA009138"],"award-info":[{"award-number":["T32 CA009138"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR000114"],"award-info":[{"award-number":["UL1TR000114"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007249","name":"University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.steroids.2016.09.004","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T19:30:41Z","timestamp":1474054241000},"page":"48-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"special_numbering":"C","title":["Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER\/PR target genes"],"prefix":"10.1016","volume":"114","author":[{"given":"Caroline H.","family":"Diep","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Ahrendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A.","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2016.09.004_b0005","doi-asserted-by":"crossref","first-page":"10696","DOI":"10.1074\/jbc.273.17.10696","article-title":"Progesterone regulates transcription of the p21(WAF1) cyclin- dependent kinase inhibitor gene through Sp1 and CBP\/p300","volume":"273","author":"Owen","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.steroids.2016.09.004_b0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0960-0760(99)00052-7","article-title":"Interactions in the transcriptional regulation exerted by Stat5 and by members of the steroid hormone receptor family","volume":"69","author":"Stoecklin","year":"1999","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.steroids.2016.09.004_b0015","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1128\/MCB.24.16.7260-7274.2004","volume":"24","author":"Cicatiello","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.steroids.2016.09.004_b0020","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1210\/me.2007-0437","article-title":"Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors","volume":"22","author":"Faivre","year":"2008","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.steroids.2016.09.004_b0025","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1093\/emboj\/17.7.2008","article-title":"Activation of the Src\/p21ras\/Erk pathway by progesterone receptor via cross-talk with estrogen receptor","volume":"17","author":"Migliaccio","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.steroids.2016.09.004_b0030","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1097-2765(01)00304-5","article-title":"Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases","volume":"8","author":"Boonyaratanakornkit","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.steroids.2016.09.004_b0035","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1128\/MCB.01539-06","article-title":"Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1\/2 mitogen-activated protein kinase in breast cancer cells","volume":"27","author":"Faivre","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.steroids.2016.09.004_b0040","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2013.11.010","article-title":"Tracking progesterone receptor-mediated actions in breast cancer","volume":"142","author":"Knutson","year":"2014","journal-title":"Pharmacol Ther."},{"key":"10.1016\/j.steroids.2016.09.004_b0045","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/j.1460-2075.1990.tb08280.x","article-title":"Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B","volume":"9","author":"Kastner","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.steroids.2016.09.004_b0050","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1210\/en.2002-220369","article-title":"Estrogen receptor alpha and activating protein-1 mediate estrogen responsiveness of the progesterone receptor gene in MCF-7 breast cancer cells","volume":"143","author":"Petz","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2016.09.004_b0055","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jsbmb.2003.11.008","article-title":"Differential regulation of the human progesterone receptor gene through an estrogen response element half site and Sp1 sites","volume":"88","author":"Petz","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.steroids.2016.09.004_b0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.gene.2003.12.003","article-title":"Transcription factor accessibility and histone acetylation of the progesterone receptor gene differs between parental MCF-7 cells and a subline that has lost progesterone receptor expression","volume":"328","author":"Xu","year":"2004","journal-title":"Gene"},{"key":"10.1016\/j.steroids.2016.09.004_b0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cell.2005.05.008","article-title":"Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1","volume":"122","author":"Carroll","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.steroids.2016.09.004_b0070","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/ng1901","article-title":"Genome-wide analysis of estrogen receptor binding sites","volume":"38","author":"Carroll","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.steroids.2016.09.004_b0075","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1128\/MCB.00083-07","article-title":"Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters","volume":"27","author":"Kininis","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.steroids.2016.09.004_b0080","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature08497","article-title":"An oestrogen-receptor-alpha-bound human chromatin interactome","volume":"462","author":"Fullwood","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.steroids.2016.09.004_b0085","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1210\/me.2009-0429","article-title":"Long-range transcriptional control of progesterone receptor gene expression","volume":"24","author":"Boney-Montoya","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.steroids.2016.09.004_b0090","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/gyno.2001.6221","article-title":"Inhibitory effects of 17beta-estradiol and progesterone on ovarian carcinoma cell proliferation: a potential role for inducible nitric oxide synthase","volume":"82","author":"Keith Bechtel","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.steroids.2016.09.004_b0095","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00000478-198704000-00006","article-title":"Histology of the ovary","volume":"11","author":"Clement","year":"1987","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.steroids.2016.09.004_b0100","series-title":"Gynecologic Endocrinology","year":"2013"},{"key":"10.1016\/j.steroids.2016.09.004_b0105","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S1470-2045(13)70448-0","article-title":"The sex hormone system in carriers of BRCA1\/2 mutations: a case-control study","volume":"14","author":"Widschwendter","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.steroids.2016.09.004_b0110","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cub.2005.01.052","article-title":"Cell-nonautonomous induction of ovarian and uterine serous cystadenomas in mice lacking a functional Brca1 in ovarian granulosa cells","volume":"15","author":"Chodankar","year":"2005","journal-title":"Curr. Biol."},{"key":"10.1016\/j.steroids.2016.09.004_b0115","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1158\/0008-5472.CAN-09-3232","article-title":"Changes in the mouse estrus cycle in response to BRCA1 inactivation suggest a potential link between risk factors for familial and sporadic ovarian cancer","volume":"70","author":"Hong","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.steroids.2016.09.004_b0120","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/labinvest.2012.58","article-title":"Alterations in Brca1 expression in mouse ovarian granulosa cells have short-term and long-term consequences on estrogen-responsive organs","volume":"92","author":"Yen","year":"2012","journal-title":"Lab. Invest."},{"key":"10.1016\/j.steroids.2016.09.004_b0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1677\/jme.0.0260011","article-title":"Immunoelectron microscopic localization of 3beta-hydroxysteroid dehydrogenase and type 5 17beta-hydroxysteroid dehydrogenase in the human prostate and mammary gland","volume":"26","author":"Pelletier","year":"2001","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.steroids.2016.09.004_b0130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1023\/A:1006009031839","article-title":"Expression of 3beta-hydroxysteroid dehydrogenase-5,4-en isomerase activity by infiltrating ductal human breast carcinoma in vitro","volume":"50","author":"Gunasegaram","year":"1998","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.steroids.2016.09.004_b0135","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1111\/j.1349-7006.2011.02018.x","article-title":"Sex steroid hormones in pairs of tumor and serum from breast cancer patients and pathobiological role of androstene-3beta, 17beta-diol","volume":"102","author":"Honma","year":"2011","journal-title":"Cancer Sci."},{"key":"10.1016\/j.steroids.2016.09.004_b0140","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jsbmb.2014.04.004","article-title":"The intracrinology of breast cancer","volume":"145","author":"McNamara","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.steroids.2016.09.004_b0145","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.celrep.2013.10.006","article-title":"Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth","volume":"5","author":"Wu","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.steroids.2016.09.004_b0150","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1126\/science.1241908","article-title":"27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology","volume":"342","author":"Nelson","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.steroids.2016.09.004_b0155","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2407-3-9","article-title":"Activity and expression of progesterone metabolizing 5alpha-reductase, 20alpha-hydroxysteroid oxidoreductase and 3alpha(beta)-hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231, T-47D) and nontumorigenic (MCF-10A) human breast cancer cells","volume":"3","author":"Wiebe","year":"2003","journal-title":"BMC Cancer"},{"key":"10.1016\/j.steroids.2016.09.004_b0160","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1677\/erc.1.01010","article-title":"Progesterone metabolites in breast cancer","volume":"13","author":"Wiebe","year":"2006","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.steroids.2016.09.004_b0165","doi-asserted-by":"crossref","unstructured":"Taplin ME MR, Logothetis C, et al. Effect of neoadjuvant abiraterone acetate (AA) plus leuprolide acetate (LHRHa) on PSA, pathological complete response (pCR), and near pCR in localized high-risk prostate cancer (LHRPC): results of a randomized phase II study. In: 2012 ASCO Annual Meeting 2012.","DOI":"10.1200\/jco.2012.30.15_suppl.4521"},{"key":"10.1016\/j.steroids.2016.09.004_b0170","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s12325-013-0050-3","article-title":"Abiraterone acetate: targeting persistent androgen dependence in castration-resistant prostate cancer","volume":"30","author":"Harshman","year":"2013","journal-title":"Adv. Ther."},{"key":"10.1016\/j.steroids.2016.09.004_b0175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2325\/jbcs.13.129","article-title":"New development in intracrinology of breast carcinoma","volume":"13","author":"Sasano","year":"2006","journal-title":"Breast Cancer"},{"key":"10.1016\/j.steroids.2016.09.004_b0180","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.beem.2008.01.003","article-title":"Intracrine androgen metabolism in prostate cancer progression: mechanisms of castration resistance and therapeutic implications","volume":"22","author":"Mostaghel","year":"2008","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"10.1016\/j.steroids.2016.09.004_b0185","doi-asserted-by":"crossref","first-page":"8651","DOI":"10.18632\/oncotarget.2354","article-title":"Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease","volume":"5","author":"Hilton","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.steroids.2016.09.004_b0190","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1158\/0008-5472.CAN-11-3290","article-title":"Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1\/MYC promoters","volume":"72","author":"Giulianelli","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.steroids.2016.09.004_b0195","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/onc.2013.579","article-title":"Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes","volume":"34","author":"Daniel","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.steroids.2016.09.004_b0200","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature14583","article-title":"Progesterone receptor modulates ERalpha action in breast cancer","volume":"523","author":"Mohammed","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.steroids.2016.09.004_b0205","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.4161\/cc.24550","article-title":"Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells","volume":"12","author":"Diep","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.steroids.2016.09.004_b0210","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/j.1460-2075.1996.tb00471.x","article-title":"Tyrosine kinase\/p21ras\/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells","volume":"15","author":"Migliaccio","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.steroids.2016.09.004_b0215","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1128\/MCB.23.6.1994-2008.2003","article-title":"Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src\/Erk pathway in mammalian cells","volume":"23","author":"Ballare","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.steroids.2016.09.004_b0220","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1186\/bcr3211","article-title":"Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression","volume":"14","author":"Knutson","year":"2012","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.steroids.2016.09.004_b0225","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1073\/pnas.97.3.1032","article-title":"Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome","volume":"97","author":"Lange","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.steroids.2016.09.004_b0230","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00880062","article-title":"The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells","volume":"11","author":"Thompson","year":"1993","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.steroids.2016.09.004_b0235","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/0006-2952(83)90474-4","article-title":"Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes","volume":"32","author":"Kontula","year":"1983","journal-title":"Biochem Pharmacol."},{"key":"10.1016\/j.steroids.2016.09.004_b0240","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mce.2005.07.001","article-title":"Synthetic progestins used in HRT have different glucocorticoid agonist properties","volume":"242","author":"Koubovec","year":"2005","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.steroids.2016.09.004_b0245","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF01806369","article-title":"Multiple actions of synthetic \u2019progestins\u2019 on the growth of ZR-75-1 human breast cancer cells: an in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids","volume":"17","author":"Poulin","year":"1991","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.steroids.2016.09.004_b0250","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10549-011-1394-5","article-title":"Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells","volume":"131","author":"Courtin","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.steroids.2016.09.004_b0255","doi-asserted-by":"crossref","first-page":"E971","DOI":"10.1152\/ajpendo.00021.2002","article-title":"Glucocorticoids stimulate human sgk1 gene expression by activation of a GRE in its 5\u2019-flanking region","volume":"283","author":"Itani","year":"2002","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2016.09.004_b0260","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1210\/me.2010-0170","article-title":"The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention","volume":"24","author":"Daniel","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.steroids.2016.09.004_b0265","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1210\/me.2003-0189","article-title":"Antiandrogen effects of mifepristone on coactivator and corepressor interactions with the androgen receptor","volume":"18","author":"Song","year":"2004","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.steroids.2016.09.004_b0270","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0959-8049(98)00388-8","article-title":"Onapristone, a progesterone receptor antagonist, as first-line therapy in primary breast cancer","volume":"35","author":"Robertson","year":"1999","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.steroids.2016.09.004_b0275","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrc3518","article-title":"Progesterone signalling in breast cancer: a neglected hormone coming into the limelight","volume":"13","author":"Brisken","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.steroids.2016.09.004_b0280","first-page":"372","article-title":"The pure antiestrogen ICI 182,780 inhibits progestin-induced transcription","volume":"59","author":"Nawaz","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.steroids.2016.09.004_b0285","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0304-3835(02)00048-4","article-title":"Inhibition of progesterone-induced VEGF production in human breast cancer cells by the pure antiestrogen ICI 182,780","volume":"181","author":"Hyder","year":"2002","journal-title":"Cancer Lett."},{"key":"10.1016\/j.steroids.2016.09.004_b0290","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1210\/mend.14.7.0493","article-title":"Sp1 binding sites and an estrogen response element half-site are involved in regulation of the human progesterone receptor A promoter","volume":"14","author":"Petz","year":"2000","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.steroids.2016.09.004_b0295","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1210\/me.2012-1066","article-title":"Gene-specific patterns of coregulator requirements by estrogen receptor-alpha in breast cancer cells","volume":"26","author":"Won Jeong","year":"2012","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.steroids.2016.09.004_b0300","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tem.2013.05.008","article-title":"Phosphorylation: a fundamental regulator of steroid receptor action","volume":"24","author":"Trevino","year":"2013","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2016.09.004_b0305","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.270.5241.1491","article-title":"Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase","volume":"270","author":"Kato","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.steroids.2016.09.004_b0310","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jcb.20087","article-title":"Differential effects of PD98059 and U0126 on osteogenesis and adipogenesis","volume":"92","author":"Dang","year":"2004","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.steroids.2016.09.004_b0315","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1210\/me.2009-0016","article-title":"Minireview: fetal-maternal hormonal signaling in pregnancy and labor","volume":"23","author":"Mendelson","year":"2009","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.steroids.2016.09.004_b0320","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.steroids.2011.02.040","article-title":"Recent data on intratumor estrogens in breast cancer","volume":"76","author":"Lonning","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2016.09.004_b0325","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/endo.134.2.8299566","article-title":"Regulation of the progesterone receptor gene by gonadotropins and cyclic adenosine 3\u2019,5\u2019-monophosphate in rat granulosa cells","volume":"134","author":"Park-Sarge","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2016.09.004_b0330","first-page":"1201","article-title":"Hormone induction of progesterone receptor (PR) messenger ribonucleic acid and activation of PR promoter regions in ovarian granulosa cells: evidence for a role of cyclic adenosine 3\u2019,5\u2019-monophosphate but not estradiol","volume":"12","author":"Clemens","year":"1998","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.steroids.2016.09.004_b0335","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1210\/me.2002-0252","article-title":"Transactivation of the progesterone receptor gene in granulosa cells: evidence that Sp1\/Sp3 binding sites in the proximal promoter play a key role in luteinizing hormone inducibility","volume":"17","author":"Sriraman","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.steroids.2016.09.004_b0340","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1210\/endo-126-2-891","article-title":"Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells: interrelationships among insulin\/insulin-like growth factor-I, serum, and estrogen","volume":"126","author":"Katzenellenbogen","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2016.09.004_b0345","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1210\/endo.134.2.7507831","article-title":"Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic adenosine 3\u2019,5\u2019-monophosphate, estradiol, insulin-like growth factor-I, and serum factors","volume":"134","author":"Cho","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2016.09.004_b0350","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1128\/MCB.21.18.6122-6131.2001","article-title":"Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294","volume":"21","author":"Shen","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.steroids.2016.09.004_b0355","doi-asserted-by":"crossref","first-page":"31308","DOI":"10.1074\/jbc.273.47.31308","article-title":"Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways","volume":"273","author":"Lange","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.steroids.2016.09.004_b0360","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/mend.11.11.0006","article-title":"Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1)","volume":"11","author":"Groshong","year":"1997","journal-title":"Mol. Endocrinol."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X16301192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X16301192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T02:44:20Z","timestamp":1601088260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X16301192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":72,"alternative-id":["S0039128X16301192"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2016.09.004","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER\/PR target genes","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2016.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}